Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE

Nature Reviews Rheumatology

Volumn 5, Issue 5, 2009, Pages 273-281

  Ju, Ji Hyeon ^a   Min, Jun Ki ^a   Jung, Chan Kwon ^a   Oh, Soon Nam ^a   Kwok, Seung Ki ^a   Kang, Kwi Young ^a   Park, Kyung Su ^a   Ko, Hyuk Jae ^a   Yoon, Chong Hyeon ^a   Park, Sung Hwan ^a   Cho, Chul Soo ^a   Kim, Ho Youn ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ABDOMINAL RADIOGRAPHY; ACUTE ABDOMEN; ACUTE DISEASE; BLOOD; COMPLEMENT ACTIVATION; DIFFERENTIAL DIAGNOSIS; GASTROENTERITIS; HUMAN; IMMUNE COMPLEX DISEASE; MESENTERIC ARTERY; MESENTERIC VEIN; MESENTERY; PANCREATITIS; PATHOLOGY; PATHOPHYSIOLOGY; PEPTIC ULCER; PERITONITIS; RADIOGRAPHY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULARIZATION; VASCULITIS;

ABDOMEN, ACUTE; ACUTE DISEASE; AUTOANTIBODIES; COMPLEMENT ACTIVATION; DIAGNOSIS, DIFFERENTIAL; GASTROENTERITIS; HUMANS; IMMUNE COMPLEX DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MESENTERIC ARTERIES; MESENTERIC VEINS; MESENTERY; PANCREATITIS; PEPTIC ULCER; PERITONITIS; RADIOGRAPHY, ABDOMINAL; VASCULITIS;

EID: 67650348460     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.53     Document Type: Article

References (103)

1. Boumpas, D. T. et al. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122, 940-950 (1995).
2. Boumpas, D. T et al. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann. Intern. Med. 123, 42-53 (1995).
3. Jovaisas, A. & Kraag, G. Acute gastrointestinal manifestations of systemic lupus erythematosus. Can. J. Surg. 30, 185-188 (1987).
4. Sultan, S. M., loannou, Y. & Isenberg, D. A. A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 38, 917-932 (1999).
5. Nadorra, R. L., Nakazato, Y & Landing, B. H. Pathologic features of gastrointestinal tract lesions in childhood-onset systemic lupus erythematosus: study of 26 patients, with review of the literature. Pediatr. Pathol. 7, 245-259 (1987).
6. Medina, F. et al. Acute abdomen in systemic lupus erythematosus: the importance of early laparotomy. Am. J. Med. 103, 100-105 (1997).
7. Passam, F. H. et al. Intestinal ischemia as the first manifestation of vasculitis. Semin. Arthritis Rheum. 34, 431-441 (2004).
8. Osler, W. Classics: On the visceral complications of erythema exudativum multiforme. Am. J. Med. Sci. 271, 106-117 (1976).
9. Houli, J. & Rezek, J. Digestive and articular manifestations of collagen diseases. A study of 55 patients. Ann. Rheum. Dis. 24, 52-56 (1965).
10. Flanigan, R. C., McDougal, W. S. & Griffen, W. O. Abdominal complications of collagen vascular disease. Am. Surg. 49, 241-244 (1983).
11. Meacham, G. C. & Weisberger, A. S. Unusual manifestations of disseminated lupus erythematosus. Ann. Intern. Med. 43, 143-152 (1955).
12. Pollak, V. E. et al. Systemic lupus erythematosus simulating acute surgical condition of the abdomen. N. Engl. J. Med. 259, 258-266 (1958).
13. Shapeero, L. G., Myers, A., Oberkircher, P E. & Miller, W. T. Acute reversible lupus vasculitis of the gastrointestinal tract. Radiology 112, 569-574 (1974).
14. Hiraishi, H. et al. Massive gastrointestinal hemorrhage in systemic lupus erythematosus: successful treatment with corticosteroid pulse therapy. Am. J. Gastroenterol. 94, 3349-3353 (1999).
15. Laing, T. J. Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide. Am. J. Med. 85, 555-558 (1988).
16. Lee, M. G., Hagley, K. & Decuaelar, K. Intestinal ischemia in systemic lupus erythematosus. J. Natl Med. Assoc. 100, 721-723 (2008).
17. Zizic, T. M., Classen, J. N. & Stevens, M. B. Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am. J. Med. 73, 525-531 (1982).
18. Drenkard, C., Villa, A. R., Reyes, E., Abello, M. & Alarcon-Segovia, D. Vasculitis in systemic lupus erythematosus. Lupus 6, 235-242 (1997).
19. Lee, C. K. et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann. Rheum. Dis. 61, 547-550 (2002).
20. Lian, T. Y, Edwards, C. J., Chan, S. P. & Chng, H. H. Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital. Lupus 12, 612-616 (2003).
21. Kwok, S. K. et al. Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody. Lupus 16, 803-809 (2007).
22. Buck, A. C., Serebro, L. H. & Quinet, R. J. Subacute abdominal pain requiring hospitalization in a systemic lupus erythematosus patient: a retrospective analysis and review of the literature. Lupus 10, 491-495 (2001).
23. Ramos-Casals, M. et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 85, 95-104 (2006).
24. Reynolds, J. C. et al. Acute pancreatitis in systemic lupus erythematosus: report of twenty cases and a review of the literature. Medicine (Baltimore) 61, 25-32 (1982).
25. Prouse, PJ., Thompson, E. M. & Gumpel, J. M. Systemic lupus erythematosus and abdominal pain. Br. J.Rheumatol. 22, 172-175 (1983).
26. Dubois, E. L. & Tuffanelli, D. L. Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA 190, 104-111 (1964).
27. Wolf, B. S. & Marshak, R. H. Segmental infarction of the small bowel. Radiology 66, 701-707 (1956).
28. Gore, R. M., Marn, C. S., Ujiki, G. T., Craig, R. M. & Marquardt, J. Ischemic colitis associated with systemic lupus erythematosus. Dis. Colon Rectum 26, 449-451 (1983).
29. Thoeni, R. F. & Cello, J. P. CT imaging of colitis. Radiology 240, 623-638 (2006).
30. Simpson, A. J. Transient ischemia of the small bowel secondary to lupus vasculitis. J. Med. Soc. N. J. 74, 868-870 (1977).
31. Kim, Y G. et al. Acute abdominal pain in systemic lupus erythematosus: factors contributing to recurrence of lupus enteritis. Ann. Rheum. Dis. 65, 1537-1538 (2006).
32. Bruce, J. & Sircus, W. Disseminated lupus erythematosus of the alimentary tract. Lancet 1, 795-798 (1959).
33. Brown, C. H., Scanlon, P J. & Haserick, J. R. Mesenteric arteritis with perforation of the jejunum in a patient with systemic lupus erythematosus. Report of a case. Cleve. Clin. Q. 31, 169-178 (1964).
34. Hermann, G. Intussusception secondary to mesenteric arteries. Complication of systemic lupus erythematosus in a 5-year-old child. JAMA 200, 74-75 (1967).
35. Ha, H. K. et al. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics 20, 779-794 (2000).
36. Taourel, P G., Deneuville, M., Pradel, J. A., Regent, D. & Bruel, J. M. Acute mesenteric ischemia: diagnosis with contrast-enhanced CT. Radiology 199, 632-636 (1996).
37. Boulter, M. et al. Unusual cranial and abdominal computed tomographic (CT) scan appearances in a case of systemic lupus erythematosus (SLE). Ann. Rheum. Dis. 46, 162-165 (1987).
38. Kirshy, D. M., Gordon, D. H. & Atweh, N. A. Abdominal computed tomography in lupus mesenteric arteritis. Comput. Med. Imaging Graph. 15, 369-372 (1991).
39. Si-Hoe, C. K., Thng, C. H., Chee, S. G., Teo, E. K. & Chng, H. H. Abdominal computed tomography in systemic lupus erythematosus. Clin. Radiol. 52, 284-289 (1997).
40. Byun, J. Y. et al. CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease. Radiology 211, 203-209 (1999).
41. Ko, S. F. et al. CT findings at lupus mesenteric vasculitis. Acta Radiol. 38, 115-120 (1997).
42. Kaushik, S. et al. Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology 218, 768-771 (2001).
43. Kaneko, Y. et al. Systemic lupus erythematosus associated with recurrent lupus enteritis and peritonitis. Clin. Rheumatol. 23, 351-354 (2004).
44. Shirato, M. et al. Imaging diagnosis of lupus enteritis—especially about sonographic findings [Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 52, 1394-1399 (1992).
45. Hizawa, K. et al. Double-contrast radiographic assessment of lupus-associated enteropathy. Clin. Radiol. 53, 825-829 (1998).
46. Endo, H. et al. Lupus enteritis detected by capsule endoscopy. Intern. Med. 46, 1621-1622 (2007).
47. Tsuchiya, M., Okazaki, I., Asakura, H. & Okubo, T. Radiographic and endoscopic features of colonic ulcers in systemic lupus erythematosus. Am. J. Gastroenterol. 64, 277-285 (1975).
48. 67Ga scan. Clin. Nucl. Med. 26, 726 (2001).
49. Stemmer, E. A. & Connolly, J. E. Mesenteric vascular insufficiency. Identification and management. Calif. Med. 118, 18-29 (1973).
50. Flaherty, M. J., Lie, J. T. & Haggitt, R. C. Mesenteric inflammatory veno-occlusive disease. A seldom recognized cause of intestinal ischemia. Am. J. Surg. Pathol. 18, 779-784 (1994).
51. Bando, H. et al. Acute acalculous cholecystitis induced by mesenteric inflammatory veno-occlusive disease (MIvOD) in systemic lupus erythematosus. Clin. Rheumatol. 22, 447-449 (2003).
52. Marston, A. Patterns of Intestinal ischaemia. Ann. R. Coll. Surg. Engl. 35, 150-181 (1964).
53. Ginzburg, L. & Klein, E. Late intestinal stenosis following strangulated hernia. Ann. Surg. 88, 204-211 (1928).
54. Hamelin, L. Mesenteric vascular insufficiency. J. Can.Assoc. Radiol. 17, 107-115 (1966).
55. Schwartz, S. et al. Roentgenologic features of vascular disorders of the intestines. Radiol. Clin. North Am. 2, 71-87 (1964).
56. Zizic, T. M., Shulman, L. E. & Stevens, M. B. Colonic perforations in systemic lupus erythematosus. Medicine (Baltimore) 54, 411-426 (1975).
57. Tsushima, Y., Uozumi, Y. & Yano, S. Reversible thickening of the bowel and urinary bladder wall in systemic lupus erythematosus: a case report. Radiat. Med. 14, 95-97 (1996).
58. Camilleri, M., Pusey, C. D., Chadwick, V. S. & Rees, A. J. Gastrointestinal manifestations of systemic vasculitis. Q. J.Med. 52, 141-149 (1983).
59. Scott, D. G., Bacon, P. A. & Tribe, C. R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 60, 288-297 (1981).
60. Helliwell, T. R., Flook, D., Whitworth, J. & Day, D. W. Arteritis and venulitis in systemic lupus erythematosus resulting in massive lower intestinal haemorrhage. Histopathology 9, 1103-1113 (1985).
61. Del Papa, N. et al. Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-32-glycoprotein I antibodies react in vitro with endothelial cells through adherent (32-glycoprotein I and induce endothelial activation. Arthritis Rheum. 40, 551-561 (1997).
62. Simantov, R. et al. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96, 2211-2219 (1995).
63. Cervera, R. et al. Intestinal involvement secondary to the antiphospholipid syndrome (APS): clinical and immunologic characteristics of 97 patients: comparison of classic and catastrophic APS. Semin. Arthritis Rheum. 36, 287-296 (2007).
64. Tomizawa, K., Sato-Matsumura, K. C. & Kajii, N. The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies. Br. J. Dermatol. 149, 439-441 (2003).
65. Cockwell, P, Tse, W. Y. & Savage, C. O. Activation of endothelial cells in thrombosis and vasculitis. Scand. J. Rheumatol. 26, 145-150 (1997).
66. Golden, B. D. & Belmont, H. M. The role of microvasculopathy in the catastrophic antiphospholipid syndrome: comment on the article by Neuwelt et al. Arthritis Rheum. 41, 751-754 (1998).
67. Schuerholz, T. et al. Terminal complement complex in septic shock with capillary leakage: marker of complement activation? Eur. J. Anaesthesiol. 22, 541-547 (2005).
68. Rees, J. D. et al. Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann. Rheum. Dis. 65, 109-111 (2006).
69. Bachmeyer, C. et al. Diffuse large and small bowel necrosis in catastrophic antiphospholipid syndrome. Eur. J. Gastroenterol. Hepatol. 18, 1011-1014 (2006).
70. Yokoi, K., Hosoi, E., Akaike, M., Shigekiyo, T. & Saito, S. Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases. Angiology 47, 315-319 (1996).
71. Tajima, C., Suzuki, Y., Mizushima, Y & Ichikawa, Y. Clinical significance of immunoglobulin A antiphospholipid antibodies: possible association with skin manifestations and small vessel vasculitis. J. Rheumatol. 25, 1730-1736 (1998).
72. Kawakami, T, Watabe, H., Mizoguchi, M. & Soma, Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schonlein purpura. Br. J. Dermatol. 155, 983-987 (2006).
73. Norden, D. K., Ostrov, B. E., Shafritz, A. B. & von Feldt, J. M. vasculitis associated with antiphospholipid syndrome. Semin. Arthritis Rheum. 24, 273-281 (1995).
74. Bordron, A. et al. Anti-endothelial cell antibody binding makes negatively charged phospholipids accessible to antiphospholipid antibodies. Arthritis Rheum. 41, 1738-1747 (1998).
75. Del Papa, N. et al. Relationship between anti-phospholipid and anti-endothelial cell antibodies III: (32 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin. Exp. Rheumatol. 13, 179-185 (1995).
76. Alessandri, C., Bombardieri, M. & Valesini, G. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv. Clin. Chem. 42, 297-326 (2006).
77. Renaudineau, Y., Dugue, C., Dueymes, M. & Youinou, P. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun. Rev. 1, 365-372 (2002).
78. Jamin, C. et al. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum. 52, 4028-4038 (2005).
79. Song, J., Park, Y. B., Lee, W. K., Lee, K. H. & Lee, S. K. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol. Int. 20, 1-7 (2000).
80. Hebbar, M. et al. Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjogren's syndrome. Ann. Rheum. Dis. 56, 230-234 (1997).
81. D'Cruz, D. P et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis. Clin. Exp. Immunol. 85, 254-261 (1991).
82. Conti, F. et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res. Ther. 6, R366-R372 (2004).
83. Apperloo-Renkema, H. Z., Bootsma, H., Mulder, B. I., Kallenberg, C. G. & van der Waaij, D. Host-microflora interaction in systemic lupus erythematosus (SLE): colonization resistance of the indigenous bacteria of the intestinal tract. Epidemiol. Infect. 112, 367-373 (1994).
84. Vilaichone, R. K. et al. Necrotizing ileitis caused by cytomegalovirus in patient with systemic lupus erythematosus: case report. J. Med. Assoc. Thai. 84 (Suppl. 1), S469-S473 (2001).
85. Bang, S. et al. CMv enteritis causing ileal perforation in underlying lupus enteritis. Clin. Rheumatol. 23, 69-72 (2004).
86. Sunkureddi, P R., Luu, N., Xiao, S. Y, Tang, W. W. & Baethge, B. A. Eosinophilic enteritis with systemic lupus erythematosus. South Med. J. 98, 1049-1052 (2005).
87. Thiefin, G. & Beaugerie, L. Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. Joint Bone Spine 72, 286–294 (2005).
88. Sheibani, S. & Gerson, L. B. Chemical colitis. J. Clin. Gastroenterol. 42, 115–121 (2008).
89. Moyer, C. F., Kodavanti, U. P., Haseman, J. K., Costa, D. L. & Nyska, A. systemic vascular disease in male B6C3F1 mice exposed to particulate matter by inhalation: studies conducted by the National Toxicology Program. Toxicol. Pathol. 30, 427–434 (2002).
90. Estes, P. C. & Cheville, N. F. The ultrastructure of vascular lesions in equine viral arteritis. Am. J. Pathol. 58, 235–253 (1970).
91. Pumarola, M. et al. Canine leishmaniasis associated with systemic vasculitis in two dogs. J. Comp. Pathol. 105, 279–286 (1991).
92. Morgan, S. J. & Van Houten, D. S. The ultrastructure of strongylus vulgaris-mediated equine chronic mesenteric arteritis. Vet. Res. Commun. 14, 41–46 (1990).
93. Morgan, S. J., Stromberg, P. C., Storts, R. W., Sowa, B. A. & Lay, J. C. Histology and morphometry of strongylus vulgaris-mediated equine mesenteric arteritis. J. Comp. Pathol. 104, 89–99 (1991).
94. Dennis, V. A., Klei, T. R., Miller, M. A., Chapman, M. R. & McClure, J. R. Immune responses of pony foals during repeated infections of Strongylus vulgaris and regular ivermectin treatments. Vet. Parasitol. 42, 83–99 (1992).
95. Johansson, S. Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. Acta Pathol. Microbiol. Scand. 89, 185–191 (1981).
96. Moses, F. M. exercise-associated intestinal ischemia. Curr. Sports Med. Rep. 4, 91–95 (2005).
97. Mecklenburg, L. et al. Mesenteritis precedes vasculitis in the rat mesentery after subacute administration of a phosphodiesterase type 4 inhibitor. Toxicol. Lett. 163, 54–64 (2006).
98. Jorgensen, L., Hovig, T., Rowsell, H. C. & Mustard, J. F. Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits. Am. J. athol. 61, 161–176 (1970).
99. Turner, H. E., Myszor, M. F., Bradlow, A. & David, J. Lupus or lupoid hepatitis with mesenteric vasculitis. Br. J. Rheumatol. 35, 1309–1311 (1996).
100. Cabrera, G. E. et al. Pneumatosis cystoides intestinalis in systemic lupus erythematosus with intestinal vasculitis: treatment with high dose prednisone. Clin. Rheumatol. 13, 312–316 (1994).
101. Parker, R. A. & Thomas, P. M. intestinal perforation and widespread arteritis in rheumatoid arthritis during treatment with cortisone. Br. Med. J. 1, 540–542 1959).
102. Grimbacher, B. et al. Successful treatment of gastrointestinal vasculitis due to systemic lupus erythematosus with intravenous pulse cyclophosphamide: a clinical case report and review of the literature. Br. J. Rheumatol. 37, 1023–1028 (1998).
103. Martin-Suarez, I. et al. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann. Rheum. Dis. 56, 481–487 (1997).